$VREOF News

Vireo Growth Inc. (VREOF) Q1 2026 Earnings Call Transcript

Vireo Growth Inc. to Release First Quarter Results on May 12, 2026

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Vireo Growth to Acquire FLUENT in All-Stock Transaction

VREOF: Vireo Growth Strong Organic Revenue Growth Supports Price Target of $1.50

Vireo Growth Inc. Partners with Ace Ventures to Establish New York’s First Minority-owned Vertically Integrated Medical Cannabis Operator

Vireo Growth Inc. Announces Closing of Acquisition of Eaze Inc.

Vireo Growth Inc. Announces Effectiveness of Management Services Agreement with PharmaCann Inc.

Vireo Growth Announces Closing of Acquisition of Assets of Schwazze

Vireo Growth Inc. Announces Closing of Acquisition of Assets of Schwazze

Vireo Growth Inc. (VREOF) Q4 2025 Earnings Call Transcript

Vireo Growth Inc. Announces Fourth Quarter 2025 Results

Vireo Growth Inc. to Release Fourth Quarter and Full Year 2025 Results on March 17, 2026

VREOF: 4Q25 Earnings Preview – Busy Quarter on the M&A Front; Meaningful Upward Revaluation on Deck, as Related Accretion Materializes

Scotts Miracle-Gro Strikes Deal to Sell Cannabis-Supply Unit

Vireo Growth Inc. Enters California and Florida and Strengthens Delivery Platforms with Acquisition of Eaze Inc.

Vireo Growth Inc. to Acquire Additional Outstanding Senior Secured Convertible Notes of Schwazze

PharmaCann Inc. Announces Sale of Certain Colorado Assets to Vireo Growth Inc.

Vireo Growth Inc. Enters into Definitive Agreement to Acquire Certain Assets of PharmaCann Inc.

Vireo Growth Inc (VREOF) Q3 2025 Earnings Call Highlights: Record Revenue Surge and Strategic ...